Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. (Q44014362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Oxidative stress in chronic hepatitis C: not just a feature of late stage disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sanjiv K Jain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Philip W Pemberton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Alexander Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Peter C Burrows

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Ali Aboutwerat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Thomas W Warnes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

805-811

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C virus infection

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Oxidative stress-related molecules and liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Fibrogenic effect of oxidative stress on rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Pathogenesis of liver fibrosis: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Iron, oxidative stress and liver fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Association between reactive oxygen species and disease activity in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

The isoprostanes. Current knowledge and directions for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Type III procollagen peptide: a marker of disease activity and prognosis in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Glutathione kinetics in normal man and in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

THE RENAL CLEARANCE OF ENDOGENOUS "CREATININE" IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

A simple fluorometric assay for lipoperoxide in blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

1 Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Vitamin E analysis methods for animal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Glutathione disulfide (GSSG) efflux from cells and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Oxidative damage and fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Can antioxidant vitamins materially reduce oxidative damage in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Biomarkers of free radical damage applications in experimental animals and in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Antioxidant properties of colchicine in acute carbon tetrachloride induced rat liver injury and its role in the resolution of established cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Chemical and biological activity of free radical 'scavengers' in allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

48 Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Selenium in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Plasma selenium in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Hepatitis C virus encodes a selenium-dependent glutathione peroxidase gene. Implications for oxidative stress as a risk factor in progression to hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Diminished plasma levels of vitamin E in patients with severe viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900060-0

7 January 2021

10.1016/S0168-8278(02)00060-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044532%20AND%20SRC:MED&resulttype=core&format=json